Skip to content
Screener

Geron GERN Total Revenue

Total Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$12.97B+5.7%
Incyte logo
IncyteINCY
$1.67B+37.7%
Immunome logo
ImmunomeIMNM
$0-100%
Exelixis logo
ExelixisEXEL
$628.69M+10.6%
CTO
Citius Oncology, Inc.CTOR
$1.67M
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.07B+19.1%

Segments

By product

See full
Gross product revenue$72.44M+25.2%
Chargebacks-$9.19M
Distributor service fees-$2.37M
Government rebates-$1.97M-329%
Sales returns and allowances-$1.43M-177%

By segment

See full
Reportable Segment$57.5M+17.3%

Other financials

Income statement

See full
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemTHREE MONTHS ENDEDJUNE 30, 2026THREE MONTHS ENDEDJUNE 30, 2025SIX MONTHS ENDEDJUNE 30, 2026SIX MONTHS ENDEDJUNE 30, 2025
Revenues:
Product revenue, net$57,473$49,007$109,244$88,443
Royalties72973196
Total revenues57,48049,036109,31788,639
Costs and operating expenses:
Cost of goods sold9,2401,19010,9322,396
Research and development22,03021,73636,98636,814
Selling, general and administrative38,86338,56474,28878,587

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's total revenue?
Geron (GERN) reported total revenue of $57.48M in Q2 2026.
How has Geron's total revenue changed year-over-year?
Geron's total revenue increased by 17.2% year-over-year, from $49.04M to $57.48M.
What is the long-term trend for Geron's total revenue?
Over 2 years (2021 to 2023), Geron's total revenue has grown at a -58.8% compound annual growth rate (CAGR), from $1.39M to $237K.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Geron's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude